BMT CTN 1703/1801 A Randomized, Multicenter Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non Myeloablative / Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation and Companion Study: Microbiome and Immune Reconstitution in Cellular Therapies and Hematopoietic Stem Cell Transplantation (Mi-Immune)

Grant

Date/time Interval

  • November 26, 2019 - November 25, 2025
  • Total Award Amount

  • 42660.00
  • Direct Costs

  • 32814.00
  • Sponsor Award Id

  • Contributor

  • Antonio Di Stasi M.D.   Investigator  
  • Donna Salzman M.D.   Investigator  
  • Luciano Costa M.D., Ph.D.   Investigator  
  • Omer Jamy   Principal Investigator  
  • Racquel Innis-Shelton M.D.   Principal Investigator  
  • Ravi Bhatia M.D.   Investigator